Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alfesca was a prominent European producer and supplier of premium and convenience food products, specializing in "festive" categories such as smoked salmon, foie gras, and chilled shellfish. Originally founded in Iceland in 1932 as SÍF (Union of Icelandic Fish Producers), the company underwent a major strategic transformation in the early 2000s, shifting from seafood trading to value-added food processing through the acquisition of the Labeyrie Group. Headquartered in Reykjavik, Alfesca operated a network of production facilities across France, the United Kingdom, and Spain, marketing its products under well-known brands including Labeyrie, Blini, and Lyons. In 2009, the company was taken private by a consortium led by the French agricultural cooperative Lur Berri and was subsequently integrated into Labeyrie Fine Foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alfesca.